Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
clinical trials
6
×
life sciences
national blog main
biotech
boston blog main
boston top stories
fda
national top stories
alexion pharmaceuticals
boston
deals
indiana blog main
indiana top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
amyotrophic lateral sclerosis (als)
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
gene therapy
gilead sciences
glaxosmithkline
hepatitis b
johnson & johnson
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
rna interference
sanofi
seattle blog main
seattle top stories
What
pharma
6
×
medicines
bio
deal
dicerna
disease
drug
new
pharmaceuticals
rna
roundup
small
abandoning
abbvie’s
advance
ago
ahead
alternative
autoimmune
baggage
biofourmis
biologics
biopharma
bucks
cancer
candidate
caught
causing
celebrate
chance
companies
congress
congressional
considered
corner
crispr
cuts
day
days
deliver
Language
unset
Current search:
pharma
×
photo
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M